1. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation;Robson;N Engl J Med,2017
2. Breast cancer;Harbeck;Nat Rev Dis Primers,2019
3. Hereditary breast and ovarian cancer: new genes in confined pathways;Nielsen;Nat Rev Canc,2016
4. Breast cancer expert committee of China anti-cancer association; cancer drug clinical research committee of China anti-cancer association. [Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2020 edition)];Zhonghua Zhong Liu Za Zhi,2020
5. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial;Tutt;Lancet,2010